SCHOLAR ROCK HOLDING CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.79 USD | -7.86% |
|
-23.15% | -42.61% |
| 05-23 | Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM | |
| 05-22 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Bio Therapeutic Drugs | -7.86% | -23.15% | -42.61% | +44.06% | -47.52% | 934M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- SRRK Stock
- Charts Scholar Rock Holding Corporation
- Comparison Chart
